10.25.2023 OMA Board Book

Obesity Medicine Association Current Period: 12-31-2022 to 10-06-2023

Portfolio Gains and Losses by Account (Year to Date) The information in this report is associated with activity on your investments held at Stifel from the beginning of the year through 10-06-2023 or year to date (YTD). We display realized gain and loss figures to assist with your portfolio analysis but this report should not be used for tax reporting or viewed as a replacement or substitution for any applicable tax document. We do not provide tax advice and would recommend you contact your tax advisor to determine the appropriate information to use in the preparation of your tax returns. As is also mentioned below, please refer to the Disclosure section at the end of this report for definitions and other important information that you should consider when reviewing this report.

Accrued Income

Statement Value

Short Term Unrealized

Long Term Unrealized ($167,470.85) ($53,480.48)

Total Unrealized ($168,271.24) ($46,900.80)

Short Term Realized ($2,894.53) ($2,894.53)

Long Term Realized $4,528.46 $4,490.96

Total Realized $1,633.93 $1,596.43

Description

Value

Taxable

$6,467,684 $13,339 $6,454,345 ($800.39)

Obesity Medicine Association (XXXX-3260) OBESITY MEDICINE ALT (XXXX-2357)

$3,878,430

$1,686

$3,876,744 $6,579.68

$848,764 $664,779 $633,869 $441,841

$0

$848,764

$0.00

$0.00

$0.00

$0.00 $0.00 $0.00 $0.00

$0.00

$0.00

OBESITY MEDICINE (XXXX-7968) OBESITY MEDICINE (XXXX-5016) OBESITY MEDICINE (XXXX-8499)

$5,488 $6,165

$659,291 ($3,589.06) $627,705 ($3,791.01)

($68,509.92) ($45,480.44)

($72,098.98) ($49,271.45)

$37.50

$37.50

$0.00 $0.00

$0.00 $0.00

$0

$441,841

$0.00

$0.00

$0.00

Total

$6,467,684 $13,339 $6,454,345 ($800.39)

($167,470.85)

($168,271.24)

($2,894.53)

$4,528.46

$1,633.93

Page 9 of 20 Please refer to the Disclosure section at the end of this report for definitions of the terms and calculations used, as well as other important information that you should consider when reviewing this report. TWR and IRR for periods of less than one year are not annualized. Account-Level and Total Portfolio performance are generally presented net of fees . Investment Product and security performance are generally presented net of associated transaction costs, including for securities held within an Investment Product, but gross of account-level fees and expenses. Review the “Performance” section of the Disclosure for a more detailed explanation and information regarding exceptions. Review the "Index Return Summary" to understand the performance of your investments relative to a representative benchmark.Periodic alternative investment valuations are adjusted by subsequent transaction activity and may also be calculated based on estimated returns. The latest valuation date is available in the Disclosure section of this report.